Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis

Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis

Atherosclerosis (AS) is a disorder of large and medium-sized arteries; it consists in the formation of lipid-rich plaques in the intima and inner media, whose pathophysiology is mostly driven by inflammation. Currently available interventions and therapies for treating atherosclerosis are not always...

Full description

Bibliographic Details
Main Authors: Antonio Cervadoro, Roberto Palomba, Giuseppe Vergaro, Roberta Cecchi, Luca Menichetti, Paolo Decuzzi, Michele Emdin, Stefano Luin
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
atherosclerosis
inflammatory diseases
smart nanomaterials
drug delivery
nanomedicine
imaging and theranostics
Online Access:https://www.frontiersin.org/article/10.3389/fbioe.2018.00177/full

Internet

https://www.frontiersin.org/article/10.3389/fbioe.2018.00177/full

Similar Items